Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
about
Roles of MAPK pathway activation during cytokine induction in BEAS-2B cells exposed to fine World Trade Center (WTC) dustGenomic characterization of remission in juvenile idiopathic arthritis.Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress.Methotrexate induced lung injury in a patient with primary CNS lymphoma: a case report.Mechanisms underlying methotrexate-induced pulmonary toxicity.Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review.Protein array diagnostics for guiding therapy in rheumatoid arthritis.Interstitial pneumonitis after treatment with pemetrexed: a rare event?Methotrexate: an old new drug in autoimmune disease.Knowledge-guided gene prioritization reveals new insights into the mechanisms of chemoresistance.Methotrexate-Induced Epithelial-Mesenchymal Transition in the Alveolar Epithelial Cell Line A549.Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction.Phospholipidosis induced by PPARγ signaling in human bronchial epithelial (BEAS-2B) cells exposed to amiodarone.Diosmin Attenuates Methotrexate-Induced Hepatic, Renal, and Cardiac Injury: A Biochemical and Histopathological Study in Mice.Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment.The effects of lycopene on intestinal injury due to methotrexate in rats.
P2860
Q23921253-226CEEB3-2ADE-4F82-9D27-523EDFF4E83CQ33775236-2C0D430F-7F8A-493C-88A5-B002548A6603Q33877053-4EB4A5E2-A609-4325-9BD1-F92895D2BAC6Q35870446-A624FAB3-3F16-484E-9CA3-37C935DAE475Q35924725-1BE83FC7-5B44-4067-A0E7-9DAA0B9546F9Q37524010-EEC47D84-FF36-4282-8532-F7BEF65A1675Q37879966-F271D171-8FD7-43C3-A03D-EEF463755566Q37952008-C5FC6232-472D-4DBC-A76D-79F3F8070E68Q37989303-47EA1593-DBAA-4448-ACAE-3CF86520250CQ38253237-B791BBCA-ADF6-4DE1-9861-B35839F0C74CQ38628538-0E653F0B-CB35-405C-B648-E3BA7A415D8FQ38733948-C95D55B4-AB15-4088-A9AF-88075EFEAE78Q39531687-EAB39A11-479E-4A79-89AA-E8BDF92657E3Q39625030-EDBEBA5E-296E-4E62-8DC9-349B5A7A429EQ41341848-90C08AA9-26C5-4A01-8E92-7A3D01128DE5Q42143644-B079B5F4-7CB1-411F-B03F-F256A3D90F5FQ47654390-1C12604B-A5E1-442B-9583-2F5987ED8EEF
P2860
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
@en
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
@nl
type
label
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
@en
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
@nl
prefLabel
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
@en
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
@nl
P2093
P1433
P1476
Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
@en
P2093
Jae-Chun Ryu
Youn-Jung Kim
P304
P356
10.1016/J.TOX.2008.11.016
P407
P577
2008-11-28T00:00:00Z